The COVID-19 pandemic has not only created a global public health crisis but also left behind complex and lasting consequences. Millions of Americans are experiencing long-term symptoms, functional impairment, and even death after contracting the coronavirus or receiving the vaccine. However, the United States still lacks FDA-approved blood tests to assess molecules that may remain in the body from the vaccine or the virus.
Currently, there are no officially approved tests in the United States to confirm the following three types of biomarkers:
Long-term residual spike protein
Vaccine-derived messenger RNA (mRNA);
Plasmid DNA fragments or other genetic material involved in the vaccine production process.
These tests have long been established in research laboratories, and some can even be obtained directly overseas. However, American patients are forced to choose expensive and risky tests shipped overseas or receive no diagnosis at all. This situation not only limits the development of scientific research but also deprives the healthcare system of essential evidence.
Medical Needs: Long-term COVID-19 patients and vaccine adverse reactions sufferers require objective data to guide treatment plans.
Scientific Research: Only by systematically collecting and analyzing relevant biomarkers can we advance our understanding of disease mechanisms in the post-pandemic era. Public Health: Without standardized testing, federal and state governments cannot make scientific decisions, and risks cannot be accurately assessed.
Social Justice: Allowing patients to suffer for extended periods without testing is both unreasonable and inhumane.
Our Demands:
The FDA should immediately initiate the review and approval process, prioritizing the evaluation of blood tests for detecting spike protein, mRNA, and DNA.
The federal government should establish dedicated funding to support the development, clinical validation, regulatory approval, and national rollout of testing technologies.
A national database should be established to systematically collect and share test results while protecting privacy, providing a reliable basis for research and policy.
In the post-pandemic era, the United States needs not only drugs and vaccines, but also scientific, transparent, and accessible diagnostic tools. Only through an FDA-approved and federally funded testing system can millions of patients receive the medical support and dignity they deserve, and build a stronger defense for the nation’s public health and future.
Comments are closed.